Work

HRAS mutations are frequent in inverted urothelial neoplasms

Year: 2014

Type: article

Study design: Observational Study

Source: Human Pathology

DOI: 10.1016/j.humpath.2014.06.003

Authors: Andrew S. McDaniel, Yali Zhai, Kathleen R. Cho, Saravana M. Dhanasekaran, Jeffrey S. Montgomery, Ganesh Palapattu, Javed Siddiqui, Todd Morgan, Ajjai Alva, Alon Weizer, Cheryl T. Lee, Arul M. Chinnaiyan, Michael J. Quist, Catherine S. Grasso, Scott A. Tomlins, Rohit Mehra

Institutions: University of Michigan, Michigan Medicine, U-M Rogel Cancer Center, Michigan Center for Translational Pathology, Howard Hughes Medical Institute, Oregon Health & Science University

Language: English

Topic: Bladder and Urothelial Cancer Treatments

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: Howard Hughes Medical Institute, National Institutes of Health, National Human Genome Research Institute, National Cancer Institute, National Center for Advancing Translational Sciences

Awards: G1815451664, A Systems Biology Approach to the Development of Cancer Biomarkers, G2585515454, G4002358668, G5403046995, Michigan Institute for Clinical and Health Research (MCHR)

OpenAlex ID: W1970879501

FWCI: 5.072

Cites: 39

Cited by: 41

Related to: 10